Publication | Open Access
Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial
155
Citations
19
References
2017
Year
| Year | Citations | |
|---|---|---|
Page 1
Page 1